Valentine's Day could bring a dazzling display of the northern lights for stargazers in some parts of the U.S.

Upgrades to Sutter Health Park are still being made with baseball season on the horizon for the River Cats and Athletics. New ...

CDMO Rentschler Biopharma is signalling its intent ... collaboration with Lyell Immunopharma in late 2022. Once a booming field for investment, cell and gene therapies have become tricky to ...

How the historic evangelical institution served a reeling Shiite community. The predominantly Shiite city of Nabatieh in southern Lebanon once boasted the nation’s largest Christmas tree ...

Or have them light automatically when someone arrives home and turn off when everyone leaves. After a new round of testing, the WiZ 60W A19 Color LED continues to be the best smart bulb.

Rentschler’s CEO said the cell and gene therapy market demand ... GSK terminated its T-cell receptor therapy collaboration with Lyell Immunopharma in late 2022. Once a booming field for investment, ...

As part of this realignment, Rentschler Biopharma will withdraw from the field of cell and gene therapy, ceasing operations at its Stevenage, UK site, and increase its focus on biologics. This ...

CDMO Rentschler Biopharma is moving out of the cell and gene therapy space and putting more of its chips behind biologics. The strategic shift means that the company will end operations at its ...

As part of this realignment, Rentschler Biopharma will withdraw from the field of cell and gene therapy, ceasing operations at its Stevenage, UK site, and increase its focus on biologics 1. This ...

As part of this realignment, Rentschler Biopharma will withdraw from the field of cell and gene therapy, ceasing operations at its Stevenage, UK site, and increase its focus on biologics1.

Rentschler Biopharma is withdrawing from the field of cell and gene therapy, ceasing operations at its Stevenage, UK site, and increasing its focus on biologics (cell culture-based therapeutic ...

Years of Experience is the number of years an individual is registered as an investment advisor only, rather than combined years of experience as either an investment advisor or broker.